MSH2 and Lynch syndrome: Whole-genome (DNA) sequencing revealed that dMMR3 and dMMR5 had a loss of function mutation in MSH2 (p.Glu483*), and inactivating mutations in MLH1 (p.I219V) and MSH3 (p.W1111R), indicating that these PDOs were derived from patients with Lynch syndrome (Figure 2).